LogicBio Therapeutics
Latest round
- Series B
Last raised
- Jun 2017
Total raised
- $33M
Investors
- 6
About LogicBio Therapeutics
LogicBio Therapeutics, Inc.Founded in 2014 and headquartered in Lexington, US, LogicBio Therapeutics, Inc. focuses on developing innovative genetic therapies.LogicBio Therapeutics, Inc. is dedicated to developing gene therapies that target genetic disorders, utilizing its proprietary genome editing technology.LogicBio Therapeutics, Inc. aims to expand its product pipeline by introducing new gene therapies designed for rare genetic disorders. The company is targeting expansion into new markets, particularly in Europe and Asia, by 2023.
Who invested in LogicBio Therapeutics
6 investors across 2 rounds
See all investors in LogicBio Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about LogicBio Therapeutics
Who invested in LogicBio Therapeutics?
LogicBio Therapeutics has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has LogicBio Therapeutics raised?
LogicBio Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did LogicBio Therapeutics last raise money?
LogicBio Therapeutics's most recent round on record is a Series B, in Jun 2017.
What does LogicBio Therapeutics do?
LogicBio Therapeutics is a biotechnology company.
Where is LogicBio Therapeutics headquartered?
LogicBio Therapeutics is headquartered in Lexington, US.
Which VCs invest in companies like LogicBio Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at LogicBio Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like LogicBio Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.